While its goal is to make drugs more affordable for patients and reduce overall drug expenditure, the FDA’s Drug Importation Program is fraught with significant challenges. The Dedham Group's Aaron McKeon-Fish shares what manufacturers need to know: https://ow.ly/WICN50Rpuz2. #HealthcareReform #DrugAffordability #PrescriptionDrugs #HealthcareCosts #PharmaIndustry
The Dedham Group’s Post
More Relevant Posts
-
Thoughts on this? >> Drugmakers submit counteroffers as part of first round of drug price negotiations >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharma #biotech #pharmaceutical #healthcare
Drugmakers submit counteroffers as part of first round of drug price negotiations
https://endpts.com
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Drugmakers submit counteroffers as part of first round of drug price negotiations >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #biotech #healthcare #pharma
Drugmakers submit counteroffers as part of first round of drug price negotiations
https://endpts.com
To view or add a comment, sign in
-
The latest from 340B Report: 340B Drug Purchases Reached $53.7 Billion in 2022, HRSA Data Show - https://lnkd.in/eTku2dce Hospital 340B Sites increased by 400% Over 11 Years, Analysis Finds - https://lnkd.in/eZgqdV84 Understanding the Impact of the Inflation Reduction Act - https://lnkd.in/e_6Vf3Qe Providers Try a Range of Responses to Manufacturer 340B Contract Pharmacy Restrictions - https://lnkd.in/ekFy2nfu Expanding 340B Eligibility Could Double Program Size, Says Report - https://lnkd.in/eQ8fG25f Senate Committee Rejects 340B Amendment to Bipartisan Health Bill - https://lnkd.in/exRD-mAU To get full access to 340B Report news reporting and analysis, visit https://lnkd.in/gJd7qNyg #340B #pharmacy #drugspharmaceuticals #hospitals #drugpricing
340B Drug Purchases Reached $53.7 Billion in 2022, HRSA Data Show - 340B Report
https://340breport.com
To view or add a comment, sign in
-
Solving the healthcare iron triangle (Cost, Access, Quality), starting with a more open drug market: Reduced cost, equal quality drugs, and more readily available options for Floridians, a triple win for patients. #healthcare #drugcost #pharmaceutical #florida
Florida Is First State Allowed to Import Drugs From Canada in Bid to Reduce Costs
wsj.com
To view or add a comment, sign in
-
FDA’s draft guidance for clinical investigation of psychedelic drugs is a tremendous step toward possible approval of #psychedelics as drug products – but is not without unique concerns. Our alert tells you more. #CMC #IND #RegulatoryHurdles #AbusePotential
FDA issues draft guidance for clinical investigations of psychedelic drugs
To view or add a comment, sign in
-
FDA’s draft guidance for clinical investigation of psychedelic drugs is a tremendous step toward possible approval of #psychedelics as drug products – but is not without unique concerns. Our alert tells you more. #CMC #IND #RegulatoryHurdles #AbusePotential
FDA issues draft guidance for clinical investigations of psychedelic drugs
To view or add a comment, sign in
-
Take a look at the remarkable achievements of the Office of New Drugs (OND) for 2023! This annual report from the OND details groundbreaking drug approvals for rare diseases to diverse efforts in managing chronic disorders and combating infectious diseases! See the full report below. #OfficeOfNewDrugs | #PublicHealth |#HealthcareInnovation |#RegulatoryScience | #DrugDevelopment | #PatientCare | #FDAApprovals
FDA’s Office of New Drugs (OND) issued their 2023 Annual Report highlighting OND’s successful year for novel drug approvals and other drug development activities that help advance the health of the American public: https://lnkd.in/e7udSaNW
To view or add a comment, sign in
-
Good overview of 2023 new drug approvals and released guidances.
FDA’s Office of New Drugs (OND) issued their 2023 Annual Report highlighting OND’s successful year for novel drug approvals and other drug development activities that help advance the health of the American public: https://lnkd.in/e7udSaNW
To view or add a comment, sign in
-
US residents pay 10x higher prices for prescription drugs despite having 7 companies among top 10 pharma globally!!! Do you know why? Three main drivers--- 1. No Price Regulator 2. Multiple intermediaries - Opaque Supply Chain 3. Unique Patent Monopoly - Evergreening Discover the shocking truths behind the soaring prices, from complex and opaque supply chains to prolonged patent monopolies. Swipe right to dive in! 📊💊 Share your thoughts or stories in the comments below. Let's start a conversation and raise awareness together! #supplychain #prescriptiondrugsUSA #Pharma #PBMs #HealthInsurance #HighPrice Follow me for more interesting business stories and in-depth case studies.
To view or add a comment, sign in
-
🚀 [Regulatory Update] The #FDA has issued a draft guidance on "Essential Drug Delivery Outputs for Devices Intended to Deliver Drugs and Biological Products." This guidance describes FDA’s recommendations related to drug delivery performance information for devices, and combination products. It includes advice on the information and data required for investigational, marketing, and post-market change applications, focusing on essential outputs for establishing and assessing drug delivery performance. 💉 💊 If you need assistance with your combination products, our consultants are at your disposal. https://lnkd.in/eDW9xSQZ #medicaldevices #combinationproducts #drugs #postmarket
To view or add a comment, sign in
-